Conference commissioners Jim Phillips, Greg Sankey, Tony Petitti, Brett Yormark and Teresa Gould spoke on next steps ...

Jonathan Mayers, Bonnaroo's co-founder, is dead. The Superfly co-founder was also a force behind Outside Lands, Clusterfest and more music festivals.

The assessment of Crohn's disease activity through endoscopy is a cornerstone of both clinical management and research. In The Lancet Gastroenterology & Hepatology, Christopher Ma and colleagues ...

Vineeth Gogineni is a Manager at Bain & Company, based in the Dallas office, serving private and public sector clients across ...

The prior article in the two-part series challenged the traditional view of economics as merely the management of scarce ...

Long-term maintenance with P2Y12 inhibitor monotherapy after discontinuing dual antiplatelet therapy (DAPT) in patients ...

When a retailer offers a chatbot to communicate with customers and solve their queries, or when a bank sends an SMS for ...

Investing.com -- Shares of Axsome Therapeutics Inc (NASDAQ: AXSM) fell 1.2% following the U.S. Food and Drug Administration’s (FDA) Refusal to File (RTF) letter regarding the company’s New Drug ...

Paradigm’s new altimeter offers real-time operational data, including rate of descent, current atmospheric pressure, alerts ...

A new gene risk score, informed by machine learning, can predict weight-loss outcomes after Roux-en-Y gastric bypass surgery.

Axsome Therapeutics (AXSM) shares drop after FDA declines review of fibromyalgia treatment AXS-14. Read more here.

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...